PORTSMOUTH, NH, Oct. 2, 2024 – Tenovi, the leader in cellular-connected remote patient monitoring (RPM) devices and data aggregation, today announced a partnership with PatchRx to bring unparalleled insight into patients’ medication-taking behaviors. Through this partnership, Tenovi will offer PatchRx’s patented medication adherence monitoring device through the Tenovi Cellular Gateway. The collaboration expands the range of device options available to healthcare providers and patients leveraging Tenovi’s remote patient monitoring technology stack: software services, device ecosystem, chronic care management solutions, and telehealth platform partners.
Fifty percent of patients report not taking their medications as prescribed. Poor medication adherence is to blame for 25% of hospitalizations and accounts for as much as 16% of healthcare costs in the U.S. By adding PatchRx’s patented medication adherence solution to its suite of connected devices, Tenovi is empowering providers with the data they need to effectively monitor, manage, and intervene in patient care, ultimately avoiding costly hospitalizations and interventions.
“Over the past five years, we’ve seen widespread adoption of remote monitoring technology, expanding access to preventative healthcare by enabling more patients to be treated outside of traditional clinical settings,” said Andrew Aertker, co-founder and CEO of PatchRx. “Uniting our technology with Tenovi’s suite of products allows us to continue to expand upon our mission to drive proactive healthcare solutions forward.”
PatchRx’s medication monitoring device connects seamlessly with Tenovi’s Cellular Gateway to transmit always-on adherence data. Tenovi has integrated over 30 third-party RPM devices with its Cellular Gateway for seamless integration that removes the cost of individual cellular connections and managing multiple devices and applications. The Cellular Gateway aggregates all data and sends it to the Tenovi Cloud, enabling clients to use their own RPM dashboards or Tenovi’s proprietary RPM platform.
“For millions of Americans suffering from chronic pain, chronic heart failure, or other chronic conditions, medication adherence plays a critical role in their health,” said Nizan Friedman, PhD., founder and CEO of Tenovi. “Our integration with PatchRx empowers providers with real-time data on patients’ medication-taking patterns, enabling care teams to break down communication barriers, more accurately assess a medication’s effectiveness, and optimize treatment plans for the best care possible.”
To demo PatchRx’s patented medication adherence monitoring device and learn more about Tenovi’s full suite of connected devices, visit us at the HLTH conference from Oct. 20-23, 2024, in Las Vegas.
About Tenovi
Tenovi is a data aggregation and automation platform connecting medical device manufacturers with remote patient monitoring companies. They provide a growing number of medical device solutions that connect with their proprietary cellular gateway to automate the transfer of patient vitals. Their API-driven fulfillment and automation services enable seamless deployment of remote patient monitoring programs.
About PatchRx
PatchRx is a medication adherence and analytics platform that improves outcomes through connected technologies. Understanding the complexities of prescription regimens, PatchRx provides personalized support through a unique service that combines a patented universal smart pill bottle device with a provider-facing web app. Over the years, PatchRx has assisted thousands of patients across various specialties with their medications, and our patient-facing services have clinically proven to support better adherence to therapy and reduce medication complications and misuse. To learn more, visit PatchRx.io.
